Immunodiagnostics Market – Drivers and Forecasts from Technavio
January 19 2017 - 2:03PM
Business Wire
Technavio analysts forecast the global
immunodiagnostics market to grow at a steady CAGR of almost 8%
during the forecast period, according to their latest report.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170119005468/en/
Technavio has published a new report on
the global immunodiagnostics market from 2017-2021. (Photo:
Business Wire)
The research study covers the present scenario and growth
prospects of the global immunodiagnostics market for
2017-2021. To calculate the market size, Technavio analysts
consider the revenue generated from the sales of immunodiagnostics
devices.
Market overview:
- Global immunodiagnostics market is well
established in developed countries like the US, the UK, Germany,
and France due to the high level of automation in laboratories for
high accuracy and efficiency.
- There are huge growth opportunities in
emerging countries like Brazil, China, and India.
- The oncology and endocrinology segment
has been the largest revenue contributor to the market in 2016. A
rise in R&D in oncology has increased the demand for
biomarker-based immunodiagnostic tests.
Request a sample report:
http://www.technavio.com/request-a-sample?report=55888
Technavio’s sample reports are free of charge and contain
multiple sections of the report including the market size and
forecast, drivers, challenges, trends, and more.
Technavio healthcare and life sciences analysts highlight
the following three factors that are contributing to the growth of
the global immunodiagnostics market:
Technological advances
The incidence of autoimmune diseases is rising worldwide, thus
increasing the volume of samples collected for analysis. This has
led to a greater demand for automation for rapid analysis and
interpretation of results from autoimmune disease diagnostics.
Automation involves a series of integrated steps that include
pre-analytical and post-analytical stages, which help lower the
need for manual intervention, thus avoiding errors.
Srinivas Sashidhar, a lead in-vitro diagnostics research
analyst at Technavio, says, “Decentralized testing for autoimmune
disease diagnosis is gaining popularity. This procedure reduces the
time spent in sending the sample for analysis from central
laboratories.”
Increasing adoption of POCT
In 2012, an emerging company, Trillium Diagnostics, licensed a
cell-free DNA sepsis marker to develop new immunodiagnostics.
Traditional companies offering sepsis POCT devices in Europe and
the US include Axis Shield, Roche Diagnostics, and bioMérieux.
“POCT for cardiovascular biomarkers is a strategic
immunodiagnostic focus area, even for non-traditional healthcare
companies. In 2011, Samsung Electronics acquired Nexus Dx, a
developer of rapid POCT for diagnosing cardiovascular diseases,”
adds Srinivas.
Product development
The rise in blood donations worldwide and stringent regulations
for approval of hematology products have led to the development of
automated hematology analyzers. With the increase in blood
donations, there are high chances of blood-related infections and
transfer of diseases.
Danaher’s automated hematology analyzers increase the accuracy
of detection of diseases in blood samples. Cell counting with
automated analyzers is rapid, objective, and significant (8,000 or
more cells can be counted), and is not subject to distributional
bias as in manual counting.
Top vendors:
- Abbott Laboratories
- Danaher
- Roche Diagnostics
- Siemens Healthineers
Browse Related Reports:
- Global Hepatitis B and C Diagnostics
Market 2016-2020
- Global Medical Imaging Left Atrial
Appendage Closure Market 2017-2021
- Clinical Immunoassay Analyzer Market
in the US 2016-2020
Become a Technavio Insights member and access all three
of these reports for a fraction of their original cost. As a
Technavio Insights member, you will have immediate access to new
reports as they’re published in addition to all 6,000+ existing
reports covering segments like oncology, and
vaccines, and medical imaging. This subscription nets
you thousands in savings, while staying connected to Technavio’s
constant transforming research library, helping you make informed
business decisions more efficiently.
About Technavio
Technavio is a leading global technology research and
advisory company. The company develops over 2000 pieces of research
every year, covering more than 500 technologies across 80
countries. Technavio has about 300 analysts globally who specialize
in customized consulting and business research assignments across
the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research
techniques to ascertain the size and vendor landscape in a range of
markets. Analysts obtain information using a combination of
bottom-up and top-down approaches, besides using in-house market
modeling tools and proprietary databases. They corroborate this
data with the data obtained from various market participants and
stakeholders across the value chain, including vendors, service
providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our
media team at media@technavio.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170119005468/en/
Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS:
+1 630 333 9501UK: +44 208 123 1770www.technavio.com